Irinotecan-based Triplet (FOLFOXIRI) as Perioperative Treatment in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to fluorouracil
Related studies linked through entity extraction aliases.
Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
- Status
- COMPLETED
- Phase
- PHASE3
Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin
- Status
- TERMINATED
- Phase
- PHASE2
SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Status
- RECRUITING
- Phase
- PHASE1
A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial
- Status
- COMPLETED
- Phase
- PHASE2
Xenotransplantation of Primary Cancer Samples in Zebrafish Embryos
- Status
- UNKNOWN
- Phase
- N/A
Avelumab in Combination With Fluorouracil and Mitomycin or Cisplatin and Radiation Therapy in Treating Participants With Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
QUILT-3.080: NANT Pancreatic Cancer Vaccine
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Potential Predictive Biomarkers in Patients Undergoing First-line Chemotherapy for Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- N/A
A Phase III Clinical Study of Napabucasin (GB201) Plus FOLFIRI in Adult Patients With Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study of Zolbetuximab (IMAB362) in Adults With Gastric Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Compare Zolbetuximab (IMAB362) and Chemotherapy With Placebo and Chemotherapy in Adults With Gastric Cancer.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
An Investigational Immunotherapy Study of Nivolumab With Standard of Care Therapy vs Standard of Care Therapy for First-Line Treatment of Colorectal Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
QUILT-3.090: NANT Squamous Cell Carcinoma (SCC) Vaccine: Subjects With SCC Who Have Progressed
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
An Immuno-therapy Study of Nivolumab in Combination With Experimental Medication BMS-986205 Compared to Standard of Care EXTREME Regimen in First-line Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE3